| |
| |
|
| Insider
Information: |
Mathers Thomas P. |
| Relationship: |
Director |
| City: |
Burlington |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
6,000 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$1,440 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
6,000 |
|
|
| Total
Value |
$1,440 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Colucid Pharmaceuticals, Inc. |
CLCD |
Chief Executive Office... |
2017-03-01 |
0 |
2015-08-25 |
0 |
Premium* |
|
|
Science 37 Holdings, Inc |
SNCE |
Director |
2020-11-20 |
6,000 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| SNCE |
Science 37 Holdings, Inc |
Director |
– • – |
2020-11-20 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
6,000 |
|
- |
|
| CLCD |
Colucid Pharmaceuticals, ... |
Chief Executive Officer |
• • – |
2017-03-01 |
4 |
D |
$46.50 |
$3,859,500 |
D/D |
(83,000) |
0 |
0 |
- |
|
| CLCD |
Colucid Pharmaceuticals, ... |
Chief Executive Officer |
• • – |
2017-03-01 |
4 |
D |
$46.50 |
$8,068,634 |
D/D |
(173,519) |
0 |
0 |
- |
|
| CLCD |
Colucid Pharmaceuticals, ... |
Chief Executive Officer |
• • – |
2017-01-05 |
4 |
AS |
$34.25 |
$52,238 |
D/D |
(1,502) |
256,519 |
0 |
- |
|
| CLCD |
Colucid Pharmaceuticals, ... |
Chief Executive Officer |
• • – |
2017-01-05 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,755 |
258,021 |
0 |
- |
|
| CLCD |
Colucid Pharmaceuticals, ... |
Chief Executive Officer |
• • – |
2016-12-05 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,756 |
255,768 |
0 |
- |
|
| CLCD |
Colucid Pharmaceuticals, ... |
Chief Executive Officer |
• • – |
2016-12-05 |
4 |
AS |
$38.75 |
$58,203 |
D/D |
(1,502) |
254,266 |
0 |
- |
|
| CLCD |
Colucid Pharmaceuticals, ... |
Chief Executive Officer |
• • – |
2016-11-07 |
4 |
AS |
$28.57 |
$42,917 |
D/D |
(1,502) |
248,920 |
0 |
- |
|
| CLCD |
Colucid Pharmaceuticals, ... |
Chief Executive Officer |
• • – |
2016-11-05 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,755 |
250,422 |
0 |
- |
|
| CLCD |
Colucid Pharmaceuticals, ... |
Chief Executive Officer |
• • – |
2016-10-05 |
4 |
AS |
$37.08 |
$55,694 |
D/D |
(1,502) |
246,667 |
0 |
- |
|
| CLCD |
Colucid Pharmaceuticals, ... |
Chief Executive Officer |
• • – |
2016-10-05 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,755 |
248,169 |
0 |
- |
|
| CLCD |
Colucid Pharmaceuticals, ... |
Chief Executive Officer |
• • – |
2016-09-07 |
4 |
AS |
$20.56 |
$111,923 |
D/D |
(5,000) |
250,414 |
0 |
- |
|
| CLCD |
Colucid Pharmaceuticals, ... |
Chief Executive Officer |
• • – |
2016-09-06 |
4 |
AS |
$19.50 |
$29,289 |
D/D |
(1,502) |
255,414 |
0 |
- |
|
| CLCD |
Colucid Pharmaceuticals, ... |
Chief Executive Officer |
• • – |
2016-09-05 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,756 |
256,916 |
0 |
- |
|
| CLCD |
Colucid Pharmaceuticals, ... |
Chief Executive Officer |
• • – |
2016-08-05 |
4 |
AS |
$8.31 |
$12,482 |
D/D |
(1,502) |
253,160 |
0 |
- |
|
| CLCD |
Colucid Pharmaceuticals, ... |
Chief Executive Officer |
• • – |
2016-08-05 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,755 |
254,662 |
0 |
- |
|
| CLCD |
Colucid Pharmaceuticals, ... |
Chief Executive Officer |
• • – |
2016-07-05 |
4 |
AS |
$9.73 |
$14,614 |
D/D |
(1,502) |
250,907 |
0 |
- |
|
| CLCD |
Colucid Pharmaceuticals, ... |
Chief Executive Officer |
• • – |
2016-07-05 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,755 |
252,409 |
0 |
- |
|
| CLCD |
Colucid Pharmaceuticals, ... |
Chief Executive Officer |
• • – |
2016-06-06 |
4 |
AS |
$7.25 |
$10,884 |
D/D |
(1,502) |
248,654 |
0 |
- |
|
| CLCD |
Colucid Pharmaceuticals, ... |
Chief Executive Officer |
• • – |
2016-06-05 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,756 |
250,156 |
0 |
- |
|
| CLCD |
Colucid Pharmaceuticals, ... |
Chief Executive Officer |
• • – |
2016-05-05 |
4 |
D |
$6.49 |
$94,910 |
D/D |
(14,624) |
241,400 |
0 |
- |
|
| CLCD |
Colucid Pharmaceuticals, ... |
Chief Executive Officer |
• • – |
2016-05-05 |
4 |
OE |
$0.00 |
$0 |
D/D |
45,064 |
256,024 |
0 |
- |
|
| CLCD |
Colucid Pharmaceuticals, ... |
Chief Executive Officer |
• • – |
2016-03-04 |
4 |
A |
$0.00 |
$0 |
D/D |
83,000 |
210,960 |
0 |
- |
|
| CLCD |
Colucid Pharmaceuticals, ... |
Chief Executive Officer |
• • – |
2015-11-05 |
4 |
D |
$4.58 |
$273,857 |
D/D |
(59,794) |
127,960 |
0 |
- |
|
| CLCD |
Colucid Pharmaceuticals, ... |
Chief Executive Officer |
• • – |
2015-11-05 |
4 |
OE |
$0.00 |
$0 |
D/D |
180,254 |
187,754 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
